Folgen
Habibeh Yekehtaz
Habibeh Yekehtaz
Emory University, Rollins School of Public Health
Bestätigte E-Mail-Adresse bei emory.edu
Titel
Zitiert von
Zitiert von
Jahr
N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study
M Farokhnia, A Azarkolah, F Adinehfar, MR Khodaie-Ardakani, ...
Clinical neuropharmacology 36 (6), 185-192, 2013
1662013
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous …
N Shahmansouri, M Farokhnia, SH Abbasi, SE Kassaian, AAN Tafti, ...
Journal of Affective disorders 155, 216-222, 2014
1542014
Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double‐blind randomized clinical …
M Farokhnia, M Shafiee Sabet, N Iranpour, A Gougol, H Yekehtaz, ...
Human Psychopharmacology: Clinical and Experimental 29 (4), 351-359, 2014
1532014
Cardiovascular considerations in antidepressant therapy: an evidence-based review
H Yekehtaz, M Farokhnia, S Akhondzadeh
The Journal of Tehran University Heart Center 8 (4), 169, 2013
1252013
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study
MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ...
Psychiatry research 215 (3), 540-546, 2014
1082014
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial
A Ghaleiha, M Ghyasvand, MR Mohammadi, M Farokhnia, N Yadegari, ...
Journal of Psychopharmacology 28 (7), 677-685, 2014
782014
Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial
A Gougol, N Zareh-Mohammadi, S Raheb, M Farokhnia, S Salimi, ...
Journal of Psychopharmacology 29 (5), 575-581, 2015
682015
Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study
MR Mohammadi, N Yadegari, E Hassanzadeh, M Farokhnia, H Yekehtaz, ...
Clinical neuropharmacology 36 (6), 179-184, 2013
592013
Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial
A Ghaleiha, E Mohammadi, MR Mohammadi, M Farokhnia, ...
Pediatric Drugs 15, 505-514, 2013
572013
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial
N Iranpour, A Zandifar, M Farokhnia, A Goguol, H Yekehtaz, ...
Human Psychopharmacology: Clinical and Experimental 31 (2), 103-112, 2016
452016
A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
M Farokhnia, M Sabzabadi, H Pourmahmoud, MR Khodaie-Ardakani, ...
Psychopharmacology 231, 533-542, 2014
442014
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia
M Noroozian, S Ghasemi, SMR Hosseini, A Modabbernia, ...
Psychopharmacology 228, 595-602, 2013
432013
Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial
SMR Hosseini, M Farokhnia, F Rezaei, A Gougol, H Yekehtaz, N Iranpour, ...
European Neuropsychopharmacology 24 (6), 846-855, 2014
232014
Developing an ethical guideline for clinical teaching in Tehran University of Medical Sciences
A Hashemi, H Yeketaz, F Asghari
Journal of Medical Ethics and History of Medicine 8, 2015
52015
Low-dose human chorionic gonadotropin adjunct to an antagonist protocol in assisted reproductive technology: a randomized trial study
M Aghahosseini, A Aleyasin, H Yekehtaz, L Kashani
Acta Medica Iranica, 430-437, 2014
52014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–15